SCHEMBL7312231

SCHEMBL7312231

COc1ccc(SC(C)(C)CC(=O)NOC(C)(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
ALDH1A1 P00352 4/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 1/20 0.40
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 2/20 0.39
ALOX15 P16050 1/20 0.39
APEX1 P27695 1/20 0.39
MAPK1 P28482 1/20 0.39
RECQL P46063 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7298900 0.85 MMP1 (0.48) MTNR1AMTNR1BCA1CA2NPC1
SCHEMBL727827 0.80 CA1 (0.43) MTNR1AMTNR1BALDH1A1CA1CA2
SCHEMBL1140787 0.79 ALDH1A1 (0.43) MTNR1AMTNR1BALDH1A1CA1CA2
SCHEMBL7862221 0.78 ALDH1A1 (0.61) MTNR1AMTNR1BALDH1A1NPC1RAB9A
SCHEMBL7305756 0.73 ALDH1A1 (0.54) ALDH1A1CA1CA2SMN1; SMN2KMT2A
SCHEMBL27891586 0.73 CA12 (0.42) MTNR1AMTNR1BALDH1A1CA1CA2
SCHEMBL13210450 0.71 CA1 (0.44) MTNR1AMTNR1BALDH1A1CA1CA2
SCHEMBL7312224 0.70 ADAM17 (0.48) MTNR1AMTNR1BALDH1A1CA1CA2
SCHEMBL7311896 0.69 MMP1 (0.50) ALDH1A1TDP1L3MBTL1MAPTKMT2A
SCHEMBL7304806 0.69 PPARG (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed